You are here: Home » PTI Stories » National » News
Business Standard

CiplaQCIL looks to partner with Uganda govt for cancer care

Press Trust of India  |  Mumbai 

Pharma Cipla's Ugandan subsidiary, Quality Chemical Industries (CiplaQCIL), today said it is looking to partner with the government of to increase access to treatments.

The company through its facility in Kampala, Uganda, manufactures antiretroviral, antimalarial and medicines to treat HIV/AIDS, and

"Faced with the growing burden of in and Africa, we once again intent on partnering with the government of to increase access to treatments," a company statement said.

The company has already partnered with the Uganda government for and treatments.

Cipla, the parent company, has been a player in in the country and other parts of the world.

"The disparities in cancer survival rates between Uganda and the developed countries can be bridged through developing local solutions to this local problem through public private partnerships," the statement added.

The company estimates around eight lakh people are suffering from cancer in Uganda, but only 4 per cent of those are able to access proper care.

It pegs the cancer survival rates at just 13 per cent, except for which stands at 46 per cent.

CiplaQCIL in November 2016 had said that it is evaluating an initial public offering (IPO) to list on Uganda bourse. (Kenya) was appointed as the

However, there is no clarity on the timeline of the IPO so far.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, June 13 2018. 20:45 IST